nodes	percent_of_prediction	percent_of_DWPC	metapath
Raltegravir—UGT1A1—Losartan—type 2 diabetes mellitus	0.252	1	CbGbCtD
Raltegravir—CCR1—cardiovascular system—type 2 diabetes mellitus	0.00502	0.243	CbGeAlD
Raltegravir—CCR1—cortex of kidney—type 2 diabetes mellitus	0.00479	0.232	CbGeAlD
Raltegravir—CCR1—adipose tissue—type 2 diabetes mellitus	0.00443	0.215	CbGeAlD
Raltegravir—CCR1—liver—type 2 diabetes mellitus	0.00311	0.15	CbGeAlD
Raltegravir—UGT1A1—kidney—type 2 diabetes mellitus	0.00202	0.0979	CbGeAlD
Raltegravir—UGT1A1—liver—type 2 diabetes mellitus	0.00128	0.0619	CbGeAlD
Raltegravir—CCR1—GPCR ligand binding—GNB3—type 2 diabetes mellitus	0.000611	0.00271	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	0.00061	0.00271	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	0.000606	0.00269	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—AVP—type 2 diabetes mellitus	0.000603	0.00268	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	0.000593	0.00263	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	0.000589	0.00262	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	0.000578	0.00257	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—EDN1—type 2 diabetes mellitus	0.000573	0.00255	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	0.000569	0.00253	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—CYP1A2—type 2 diabetes mellitus	0.000559	0.00248	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—ABCC2—type 2 diabetes mellitus	0.000554	0.00246	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	0.000539	0.00239	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	0.000525	0.00233	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000523	0.00232	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	0.000516	0.00229	CbGpPWpGaD
Raltegravir—CCR1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	0.000515	0.00229	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	0.000513	0.00228	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	0.000512	0.00227	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—C3—type 2 diabetes mellitus	0.000501	0.00223	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	0.0005	0.00222	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	0.000497	0.00221	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.000481	0.00214	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.000481	0.00214	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC2A2—type 2 diabetes mellitus	0.000481	0.00214	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	0.000476	0.00211	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—AGT—type 2 diabetes mellitus	0.000476	0.00211	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	0.000465	0.00207	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	0.000462	0.00205	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	0.000454	0.00202	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	0.000451	0.00201	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	0.000449	0.002	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.00044	0.00196	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	0.00044	0.00195	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	0.000438	0.00195	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	0.000433	0.00192	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	0.000432	0.00192	CbGpPWpGaD
Raltegravir—UGT1A1—Phase II conjugation—GSTM1—type 2 diabetes mellitus	0.000428	0.0019	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000424	0.00188	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	0.00042	0.00186	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—MTR—type 2 diabetes mellitus	0.000413	0.00184	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	0.000408	0.00181	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000402	0.00179	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	0.000401	0.00178	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP11A1—type 2 diabetes mellitus	0.0004	0.00178	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	0.000399	0.00177	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	0.000398	0.00177	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	0.000395	0.00175	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	0.000394	0.00175	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	0.000393	0.00175	CbGpPWpGaD
Raltegravir—CCR1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	0.000392	0.00174	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000385	0.00171	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000374	0.00166	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC2A1—type 2 diabetes mellitus	0.000373	0.00166	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GCG—type 2 diabetes mellitus	0.000364	0.00162	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.00036	0.0016	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	0.000358	0.00159	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—SLC2A4—type 2 diabetes mellitus	0.000357	0.00159	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000348	0.00155	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	0.000345	0.00153	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	0.000341	0.00151	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP2E1—type 2 diabetes mellitus	0.00033	0.00147	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—type 2 diabetes mellitus	0.000328	0.00146	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP1A2—type 2 diabetes mellitus	0.000327	0.00145	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	0.000326	0.00145	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	0.000324	0.00144	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	0.000322	0.00143	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000321	0.00143	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—CYP3A4—type 2 diabetes mellitus	0.000319	0.00142	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000318	0.00141	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000318	0.00141	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—CYP3A4—type 2 diabetes mellitus	0.000314	0.0014	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	0.000314	0.00139	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFBR2—type 2 diabetes mellitus	0.000311	0.00138	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.00031	0.00138	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.00031	0.00138	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AVP—type 2 diabetes mellitus	0.000309	0.00137	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	0.000309	0.00137	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	0.000308	0.00137	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—HMOX1—type 2 diabetes mellitus	0.000306	0.00136	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000305	0.00136	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	0.000294	0.00131	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—type 2 diabetes mellitus	0.000293	0.0013	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	0.00029	0.00129	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—type 2 diabetes mellitus	0.000287	0.00128	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—GSTM1—type 2 diabetes mellitus	0.000286	0.00127	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—C3—type 2 diabetes mellitus	0.000283	0.00126	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	0.000279	0.00124	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	0.000276	0.00123	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—AGER—type 2 diabetes mellitus	0.000275	0.00122	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IAPP—type 2 diabetes mellitus	0.000275	0.00122	CbGpPWpGaD
Raltegravir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—type 2 diabetes mellitus	0.000274	0.00122	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—INSR—type 2 diabetes mellitus	0.000273	0.00121	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	0.000269	0.00119	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	0.000268	0.00119	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	0.000268	0.00119	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	0.000267	0.00118	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	0.000263	0.00117	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—C3—type 2 diabetes mellitus	0.000257	0.00114	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	0.000255	0.00113	CbGpPWpGaD
Raltegravir—UGT1A1—Biological oxidations—GSTM1—type 2 diabetes mellitus	0.00025	0.00111	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	0.000248	0.0011	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	0.000248	0.0011	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	0.000248	0.0011	CbGpPWpGaD
Raltegravir—UGT1A1—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	0.000247	0.0011	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AGT—type 2 diabetes mellitus	0.000244	0.00108	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	0.000241	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	0.00024	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CYBA—type 2 diabetes mellitus	0.00024	0.00107	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	0.000236	0.00105	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PLAT—type 2 diabetes mellitus	0.000235	0.00104	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GHRL—type 2 diabetes mellitus	0.000235	0.00104	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CALCA—type 2 diabetes mellitus	0.000232	0.00103	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	0.000226	0.001	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	0.000219	0.000971	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	0.000218	0.000967	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—GCG—type 2 diabetes mellitus	0.000215	0.000955	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	0.000215	0.000955	CbGpPWpGaD
Raltegravir—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000213	0.000424	CcSEcCtD
Raltegravir—Nausea—Glipizide—type 2 diabetes mellitus	0.000213	0.000423	CcSEcCtD
Raltegravir—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000212	0.000423	CcSEcCtD
Raltegravir—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000212	0.000421	CcSEcCtD
Raltegravir—Constipation—Gliclazide—type 2 diabetes mellitus	0.000212	0.000421	CcSEcCtD
Raltegravir—Pain—Gliclazide—type 2 diabetes mellitus	0.000212	0.000421	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	0.000211	0.000939	CbGpPWpGaD
Raltegravir—Tremor—Losartan—type 2 diabetes mellitus	0.000211	0.00042	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	0.000211	0.000936	CbGpPWpGaD
Raltegravir—Rash—Glimepiride—type 2 diabetes mellitus	0.000211	0.000419	CcSEcCtD
Raltegravir—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00021	0.000419	CcSEcCtD
Raltegravir—Rash—Sitagliptin—type 2 diabetes mellitus	0.00021	0.000418	CcSEcCtD
Raltegravir—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00021	0.000417	CcSEcCtD
Raltegravir—Erythema multiforme—Ramipril—type 2 diabetes mellitus	0.00021	0.000417	CcSEcCtD
Raltegravir—Headache—Glimepiride—type 2 diabetes mellitus	0.000209	0.000416	CcSEcCtD
Raltegravir—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000209	0.000416	CcSEcCtD
Raltegravir—Cough—Irbesartan—type 2 diabetes mellitus	0.000209	0.000416	CcSEcCtD
Raltegravir—Headache—Sitagliptin—type 2 diabetes mellitus	0.000209	0.000415	CcSEcCtD
Raltegravir—Anaemia—Losartan—type 2 diabetes mellitus	0.000208	0.000414	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000207	0.000412	CcSEcCtD
Raltegravir—Agitation—Losartan—type 2 diabetes mellitus	0.000207	0.000412	CcSEcCtD
Raltegravir—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000207	0.000412	CcSEcCtD
Raltegravir—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000207	0.000411	CcSEcCtD
Raltegravir—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00041	CcSEcCtD
Raltegravir—Infection—Metformin—type 2 diabetes mellitus	0.000206	0.000409	CcSEcCtD
Raltegravir—Insomnia—Valsartan—type 2 diabetes mellitus	0.000206	0.000409	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000205	0.000407	CcSEcCtD
Raltegravir—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000204	0.000406	CcSEcCtD
Raltegravir—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000204	0.000406	CcSEcCtD
Raltegravir—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000204	0.000405	CcSEcCtD
Raltegravir—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000204	0.000405	CcSEcCtD
Raltegravir—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000204	0.000405	CcSEcCtD
Raltegravir—Insomnia—Orlistat—type 2 diabetes mellitus	0.000203	0.000404	CcSEcCtD
Raltegravir—Malaise—Losartan—type 2 diabetes mellitus	0.000203	0.000404	CcSEcCtD
Raltegravir—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000203	0.000404	CcSEcCtD
Raltegravir—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000203	0.000404	CcSEcCtD
Raltegravir—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000203	0.000404	CcSEcCtD
Raltegravir—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000203	0.000403	CcSEcCtD
Raltegravir—Vertigo—Losartan—type 2 diabetes mellitus	0.000202	0.000403	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000202	0.000403	CcSEcCtD
Raltegravir—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000202	0.000402	CcSEcCtD
Raltegravir—Somnolence—Valsartan—type 2 diabetes mellitus	0.000202	0.000402	CcSEcCtD
Raltegravir—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000202	0.000401	CcSEcCtD
Raltegravir—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000201	0.000401	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	0.000201	0.000894	CbGpPWpGaD
Raltegravir—Skin disorder—Metformin—type 2 diabetes mellitus	0.000201	0.0004	CcSEcCtD
Raltegravir—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.0002	0.000399	CcSEcCtD
Raltegravir—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.0002	0.000398	CcSEcCtD
Raltegravir—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.0002	0.000398	CcSEcCtD
Raltegravir—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.0002	0.000398	CcSEcCtD
Raltegravir—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000199	0.000397	CcSEcCtD
Raltegravir—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000199	0.000396	CcSEcCtD
Raltegravir—Palpitations—Losartan—type 2 diabetes mellitus	0.000199	0.000396	CcSEcCtD
Raltegravir—Nausea—Glimepiride—type 2 diabetes mellitus	0.000198	0.000395	CcSEcCtD
Raltegravir—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000198	0.000394	CcSEcCtD
Raltegravir—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000198	0.000393	CcSEcCtD
Raltegravir—Asthenia—Glyburide—type 2 diabetes mellitus	0.000198	0.000393	CcSEcCtD
Raltegravir—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000198	0.000393	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	0.000198	0.000878	CbGpPWpGaD
Raltegravir—CCR1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	0.000197	0.000877	CbGpPWpGaD
Raltegravir—Cough—Losartan—type 2 diabetes mellitus	0.000197	0.000391	CcSEcCtD
Raltegravir—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000197	0.000391	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000196	0.00039	CcSEcCtD
Raltegravir—Alopecia—Ramipril—type 2 diabetes mellitus	0.000196	0.00039	CcSEcCtD
Raltegravir—Fatigue—Valsartan—type 2 diabetes mellitus	0.000196	0.00039	CcSEcCtD
Raltegravir—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000196	0.000389	CcSEcCtD
Raltegravir—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000196	0.000389	CcSEcCtD
Raltegravir—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000195	0.000388	CcSEcCtD
Raltegravir—Pruritus—Glyburide—type 2 diabetes mellitus	0.000195	0.000388	CcSEcCtD
Raltegravir—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000194	0.000387	CcSEcCtD
Raltegravir—Constipation—Valsartan—type 2 diabetes mellitus	0.000194	0.000387	CcSEcCtD
Raltegravir—Infection—Irbesartan—type 2 diabetes mellitus	0.000194	0.000386	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000194	0.000386	CcSEcCtD
Raltegravir—Fatigue—Orlistat—type 2 diabetes mellitus	0.000194	0.000385	CcSEcCtD
Raltegravir—Erythema—Ramipril—type 2 diabetes mellitus	0.000193	0.000384	CcSEcCtD
Raltegravir—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000193	0.000384	CcSEcCtD
Raltegravir—Pain—Orlistat—type 2 diabetes mellitus	0.000192	0.000382	CcSEcCtD
Raltegravir—Arthralgia—Losartan—type 2 diabetes mellitus	0.000192	0.000382	CcSEcCtD
Raltegravir—Myalgia—Losartan—type 2 diabetes mellitus	0.000192	0.000382	CcSEcCtD
Raltegravir—Chest pain—Losartan—type 2 diabetes mellitus	0.000192	0.000382	CcSEcCtD
Raltegravir—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000192	0.000381	CcSEcCtD
Raltegravir—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000192	0.000381	CcSEcCtD
Raltegravir—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000191	0.000381	CcSEcCtD
Raltegravir—Anxiety—Losartan—type 2 diabetes mellitus	0.000191	0.00038	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—BHMT—type 2 diabetes mellitus	0.000191	0.000849	CbGpPWpGaD
Raltegravir—Rash—Bromocriptine—type 2 diabetes mellitus	0.00019	0.000378	CcSEcCtD
Raltegravir—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00019	0.000378	CcSEcCtD
Raltegravir—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00019	0.000377	CcSEcCtD
Raltegravir—Discomfort—Losartan—type 2 diabetes mellitus	0.000189	0.000377	CcSEcCtD
Raltegravir—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000189	0.000376	CcSEcCtD
Raltegravir—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000189	0.000376	CcSEcCtD
Raltegravir—Headache—Bromocriptine—type 2 diabetes mellitus	0.000189	0.000376	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000189	0.000375	CcSEcCtD
Raltegravir—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000189	0.000375	CcSEcCtD
Raltegravir—Nervousness—Ramipril—type 2 diabetes mellitus	0.000188	0.000373	CcSEcCtD
Raltegravir—Dry mouth—Losartan—type 2 diabetes mellitus	0.000188	0.000373	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	0.000187	0.000831	CbGpPWpGaD
Raltegravir—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000186	0.00037	CcSEcCtD
Raltegravir—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000186	0.00037	CcSEcCtD
Raltegravir—Confusional state—Losartan—type 2 diabetes mellitus	0.000185	0.000369	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—GNB3—type 2 diabetes mellitus	0.000185	0.000823	CbGpPWpGaD
Raltegravir—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000185	0.000368	CcSEcCtD
Raltegravir—Somnolence—Metformin—type 2 diabetes mellitus	0.000184	0.000366	CcSEcCtD
Raltegravir—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000184	0.000365	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—AVP—type 2 diabetes mellitus	0.000183	0.000812	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP3—type 2 diabetes mellitus	0.000183	0.000812	CbGpPWpGaD
Raltegravir—Infection—Losartan—type 2 diabetes mellitus	0.000183	0.000363	CcSEcCtD
Raltegravir—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000182	0.000363	CcSEcCtD
Raltegravir—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000182	0.000362	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IGF2—type 2 diabetes mellitus	0.000182	0.000808	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	0.000181	0.000805	CbGpPWpGaD
Raltegravir—Tremor—Ramipril—type 2 diabetes mellitus	0.000181	0.00036	CcSEcCtD
Raltegravir—Urticaria—Valsartan—type 2 diabetes mellitus	0.000181	0.000359	CcSEcCtD
Raltegravir—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.00018	0.000359	CcSEcCtD
Raltegravir—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00018	0.000358	CcSEcCtD
Raltegravir—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00018	0.000358	CcSEcCtD
Raltegravir—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.00018	0.000357	CcSEcCtD
Raltegravir—CCR1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	0.000179	0.000796	CbGpPWpGaD
Raltegravir—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000179	0.000357	CcSEcCtD
Raltegravir—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000179	0.000356	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000179	0.000356	CcSEcCtD
Raltegravir—Fatigue—Metformin—type 2 diabetes mellitus	0.000178	0.000355	CcSEcCtD
Raltegravir—Urticaria—Orlistat—type 2 diabetes mellitus	0.000178	0.000355	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000178	0.000354	CcSEcCtD
Raltegravir—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000178	0.000354	CcSEcCtD
Raltegravir—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000178	0.000353	CcSEcCtD
Raltegravir—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000178	0.000353	CcSEcCtD
Raltegravir—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000178	0.000353	CcSEcCtD
Raltegravir—Agitation—Ramipril—type 2 diabetes mellitus	0.000177	0.000353	CcSEcCtD
Raltegravir—Constipation—Metformin—type 2 diabetes mellitus	0.000177	0.000352	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—APOB—type 2 diabetes mellitus	0.000177	0.000785	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	0.000176	0.000781	CbGpPWpGaD
Raltegravir—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000175	0.000349	CcSEcCtD
Raltegravir—Vomiting—Glyburide—type 2 diabetes mellitus	0.000175	0.000349	CcSEcCtD
Raltegravir—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000175	0.000348	CcSEcCtD
Raltegravir—Malaise—Ramipril—type 2 diabetes mellitus	0.000174	0.000347	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—EDN1—type 2 diabetes mellitus	0.000174	0.000772	CbGpPWpGaD
Raltegravir—Rash—Glyburide—type 2 diabetes mellitus	0.000174	0.000346	CcSEcCtD
Raltegravir—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000174	0.000345	CcSEcCtD
Raltegravir—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000174	0.000345	CcSEcCtD
Raltegravir—Vertigo—Ramipril—type 2 diabetes mellitus	0.000174	0.000345	CcSEcCtD
Raltegravir—Headache—Glyburide—type 2 diabetes mellitus	0.000173	0.000343	CcSEcCtD
Raltegravir—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000172	0.000342	CcSEcCtD
Raltegravir—Palpitations—Ramipril—type 2 diabetes mellitus	0.000171	0.00034	CcSEcCtD
Raltegravir—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000171	0.000339	CcSEcCtD
Raltegravir—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.00017	0.000338	CcSEcCtD
Raltegravir—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000169	0.000337	CcSEcCtD
Raltegravir—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000169	0.000337	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000169	0.000336	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—LPL—type 2 diabetes mellitus	0.000169	0.000749	CbGpPWpGaD
Raltegravir—Cough—Ramipril—type 2 diabetes mellitus	0.000169	0.000335	CcSEcCtD
Raltegravir—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000168	0.000335	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000167	0.000333	CcSEcCtD
Raltegravir—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000167	0.000333	CcSEcCtD
Raltegravir—Pain—Irbesartan—type 2 diabetes mellitus	0.000167	0.000332	CcSEcCtD
Raltegravir—Constipation—Irbesartan—type 2 diabetes mellitus	0.000167	0.000332	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—PTGDS—type 2 diabetes mellitus	0.000167	0.000742	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AANAT—type 2 diabetes mellitus	0.000167	0.000742	CbGpPWpGaD
Raltegravir—Insomnia—Losartan—type 2 diabetes mellitus	0.000166	0.000331	CcSEcCtD
Raltegravir—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000165	0.000329	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	0.000165	0.000733	CbGpPWpGaD
Raltegravir—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000165	0.000328	CcSEcCtD
Raltegravir—Urticaria—Metformin—type 2 diabetes mellitus	0.000164	0.000327	CcSEcCtD
Raltegravir—Myalgia—Ramipril—type 2 diabetes mellitus	0.000164	0.000327	CcSEcCtD
Raltegravir—Chest pain—Ramipril—type 2 diabetes mellitus	0.000164	0.000327	CcSEcCtD
Raltegravir—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000164	0.000327	CcSEcCtD
Raltegravir—Anxiety—Ramipril—type 2 diabetes mellitus	0.000164	0.000326	CcSEcCtD
Raltegravir—Nausea—Glyburide—type 2 diabetes mellitus	0.000164	0.000326	CcSEcCtD
Raltegravir—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000164	0.000326	CcSEcCtD
Raltegravir—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000164	0.000325	CcSEcCtD
Raltegravir—Somnolence—Losartan—type 2 diabetes mellitus	0.000163	0.000325	CcSEcCtD
Raltegravir—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000163	0.000325	CcSEcCtD
Raltegravir—Asthenia—Valsartan—type 2 diabetes mellitus	0.000163	0.000324	CcSEcCtD
Raltegravir—Discomfort—Ramipril—type 2 diabetes mellitus	0.000162	0.000323	CcSEcCtD
Raltegravir—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000162	0.000322	CcSEcCtD
Raltegravir—Asthenia—Orlistat—type 2 diabetes mellitus	0.000161	0.000321	CcSEcCtD
Raltegravir—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000161	0.00032	CcSEcCtD
Raltegravir—Pruritus—Valsartan—type 2 diabetes mellitus	0.000161	0.00032	CcSEcCtD
Raltegravir—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000161	0.00032	CcSEcCtD
Raltegravir—Decreased appetite—Losartan—type 2 diabetes mellitus	0.00016	0.000318	CcSEcCtD
Raltegravir—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.00016	0.000318	CcSEcCtD
Raltegravir—Confusional state—Ramipril—type 2 diabetes mellitus	0.000159	0.000316	CcSEcCtD
Raltegravir—Pruritus—Orlistat—type 2 diabetes mellitus	0.000159	0.000316	CcSEcCtD
Raltegravir—Fatigue—Losartan—type 2 diabetes mellitus	0.000158	0.000315	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GPD2—type 2 diabetes mellitus	0.000158	0.000703	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CDO1—type 2 diabetes mellitus	0.000158	0.000703	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	0.000158	0.000703	CbGpPWpGaD
Raltegravir—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000157	0.000313	CcSEcCtD
Raltegravir—Pain—Losartan—type 2 diabetes mellitus	0.000157	0.000313	CcSEcCtD
Raltegravir—Constipation—Losartan—type 2 diabetes mellitus	0.000157	0.000313	CcSEcCtD
Raltegravir—Rash—Gliclazide—type 2 diabetes mellitus	0.000156	0.00031	CcSEcCtD
Raltegravir—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000156	0.00031	CcSEcCtD
Raltegravir—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000156	0.000309	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CCR5—type 2 diabetes mellitus	0.000155	0.00069	CbGpPWpGaD
Raltegravir—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000155	0.000309	CcSEcCtD
Raltegravir—Headache—Gliclazide—type 2 diabetes mellitus	0.000155	0.000308	CcSEcCtD
Raltegravir—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000155	0.000308	CcSEcCtD
Raltegravir—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000154	0.000307	CcSEcCtD
Raltegravir—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000154	0.000307	CcSEcCtD
Raltegravir—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000154	0.000307	CcSEcCtD
Raltegravir—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000154	0.000306	CcSEcCtD
Raltegravir—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000153	0.000305	CcSEcCtD
Raltegravir—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.000152	0.000303	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—C3—type 2 diabetes mellitus	0.000152	0.000675	CbGpPWpGaD
Raltegravir—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000151	0.000301	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—AK1—type 2 diabetes mellitus	0.000151	0.000671	CbGpPWpGaD
Raltegravir—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.00015	0.000299	CcSEcCtD
Raltegravir—Dizziness—Valsartan—type 2 diabetes mellitus	0.00015	0.000299	CcSEcCtD
Raltegravir—Dizziness—Orlistat—type 2 diabetes mellitus	0.000149	0.000295	CcSEcCtD
Raltegravir—Asthenia—Metformin—type 2 diabetes mellitus	0.000149	0.000295	CcSEcCtD
Raltegravir—Nausea—Gliclazide—type 2 diabetes mellitus	0.000147	0.000292	CcSEcCtD
Raltegravir—Pruritus—Metformin—type 2 diabetes mellitus	0.000146	0.000291	CcSEcCtD
Raltegravir—Urticaria—Losartan—type 2 diabetes mellitus	0.000146	0.000291	CcSEcCtD
Raltegravir—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000145	0.000289	CcSEcCtD
Raltegravir—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000145	0.000289	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	0.000145	0.000643	CbGpPWpGaD
Raltegravir—Vomiting—Valsartan—type 2 diabetes mellitus	0.000145	0.000288	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IRS2—type 2 diabetes mellitus	0.000144	0.000642	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AGT—type 2 diabetes mellitus	0.000144	0.000641	CbGpPWpGaD
Raltegravir—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000144	0.000286	CcSEcCtD
Raltegravir—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000144	0.000286	CcSEcCtD
Raltegravir—Rash—Valsartan—type 2 diabetes mellitus	0.000143	0.000285	CcSEcCtD
Raltegravir—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000143	0.000285	CcSEcCtD
Raltegravir—Vomiting—Orlistat—type 2 diabetes mellitus	0.000143	0.000284	CcSEcCtD
Raltegravir—Insomnia—Ramipril—type 2 diabetes mellitus	0.000143	0.000284	CcSEcCtD
Raltegravir—Headache—Valsartan—type 2 diabetes mellitus	0.000142	0.000283	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—CALM1—type 2 diabetes mellitus	0.000142	0.00063	CbGpPWpGaD
Raltegravir—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000142	0.000282	CcSEcCtD
Raltegravir—Rash—Orlistat—type 2 diabetes mellitus	0.000142	0.000282	CcSEcCtD
Raltegravir—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000142	0.000282	CcSEcCtD
Raltegravir—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000141	0.000281	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—APOE—type 2 diabetes mellitus	0.000141	0.000628	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—LEP—type 2 diabetes mellitus	0.000141	0.000628	CbGpPWpGaD
Raltegravir—Headache—Orlistat—type 2 diabetes mellitus	0.000141	0.00028	CcSEcCtD
Raltegravir—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00014	0.000279	CcSEcCtD
Raltegravir—Somnolence—Ramipril—type 2 diabetes mellitus	0.00014	0.000279	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—APOA1—type 2 diabetes mellitus	0.00014	0.000621	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000139	0.000619	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MAT1A—type 2 diabetes mellitus	0.000139	0.000619	CbGpPWpGaD
Raltegravir—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000139	0.000276	CcSEcCtD
Raltegravir—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000138	0.000275	CcSEcCtD
Raltegravir—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000137	0.000273	CcSEcCtD
Raltegravir—Dizziness—Metformin—type 2 diabetes mellitus	0.000137	0.000272	CcSEcCtD
Raltegravir—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000136	0.000271	CcSEcCtD
Raltegravir—Fatigue—Ramipril—type 2 diabetes mellitus	0.000136	0.00027	CcSEcCtD
Raltegravir—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000135	0.000269	CcSEcCtD
Raltegravir—Nausea—Valsartan—type 2 diabetes mellitus	0.000135	0.000269	CcSEcCtD
Raltegravir—Constipation—Ramipril—type 2 diabetes mellitus	0.000135	0.000268	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000135	0.000598	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HBA2—type 2 diabetes mellitus	0.000135	0.000598	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ENPP1—type 2 diabetes mellitus	0.000135	0.000598	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ND1—type 2 diabetes mellitus	0.000135	0.000598	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—G6PC—type 2 diabetes mellitus	0.000135	0.000598	CbGpPWpGaD
Raltegravir—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000134	0.000266	CcSEcCtD
Raltegravir—Nausea—Orlistat—type 2 diabetes mellitus	0.000133	0.000265	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	0.000133	0.000592	CbGpPWpGaD
Raltegravir—Asthenia—Losartan—type 2 diabetes mellitus	0.000132	0.000262	CcSEcCtD
Raltegravir—Vomiting—Metformin—type 2 diabetes mellitus	0.000132	0.000262	CcSEcCtD
Raltegravir—Rash—Metformin—type 2 diabetes mellitus	0.000131	0.00026	CcSEcCtD
Raltegravir—Dermatitis—Metformin—type 2 diabetes mellitus	0.00013	0.000259	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—GCGR—type 2 diabetes mellitus	0.00013	0.000579	CbGpPWpGaD
Raltegravir—Pruritus—Losartan—type 2 diabetes mellitus	0.00013	0.000259	CcSEcCtD
Raltegravir—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00013	0.000258	CcSEcCtD
Raltegravir—Headache—Metformin—type 2 diabetes mellitus	0.00013	0.000258	CcSEcCtD
Raltegravir—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000129	0.000257	CcSEcCtD
Raltegravir—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000129	0.000256	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IRS1—type 2 diabetes mellitus	0.000126	0.00056	CbGpPWpGaD
Raltegravir—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000126	0.00025	CcSEcCtD
Raltegravir—Urticaria—Ramipril—type 2 diabetes mellitus	0.000125	0.000249	CcSEcCtD
Raltegravir—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000125	0.000248	CcSEcCtD
Raltegravir—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000125	0.000248	CcSEcCtD
Raltegravir—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000124	0.000247	CcSEcCtD
Raltegravir—Rash—Irbesartan—type 2 diabetes mellitus	0.000123	0.000245	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—CYTB—type 2 diabetes mellitus	0.000123	0.000547	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—OXCT1—type 2 diabetes mellitus	0.000123	0.000547	CbGpPWpGaD
Raltegravir—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000123	0.000245	CcSEcCtD
Raltegravir—Nausea—Metformin—type 2 diabetes mellitus	0.000123	0.000245	CcSEcCtD
Raltegravir—Headache—Irbesartan—type 2 diabetes mellitus	0.000122	0.000243	CcSEcCtD
Raltegravir—Dizziness—Losartan—type 2 diabetes mellitus	0.000122	0.000242	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—INS—type 2 diabetes mellitus	0.000121	0.000537	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SRD5A1—type 2 diabetes mellitus	0.00012	0.000533	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CCL2—type 2 diabetes mellitus	0.000119	0.000528	CbGpPWpGaD
Raltegravir—Vomiting—Losartan—type 2 diabetes mellitus	0.000117	0.000233	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—IGF1—type 2 diabetes mellitus	0.000117	0.000519	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT2—type 2 diabetes mellitus	0.000117	0.000519	CbGpPWpGaD
Raltegravir—UGT1A1—NRF2 pathway—TGFB1—type 2 diabetes mellitus	0.000116	0.000517	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	0.000116	0.000516	CbGpPWpGaD
Raltegravir—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000116	0.000231	CcSEcCtD
Raltegravir—Nausea—Irbesartan—type 2 diabetes mellitus	0.000116	0.000231	CcSEcCtD
Raltegravir—Rash—Losartan—type 2 diabetes mellitus	0.000116	0.000231	CcSEcCtD
Raltegravir—Dermatitis—Losartan—type 2 diabetes mellitus	0.000116	0.00023	CcSEcCtD
Raltegravir—Headache—Losartan—type 2 diabetes mellitus	0.000115	0.000229	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—ACACA—type 2 diabetes mellitus	0.000114	0.000508	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—STAR—type 2 diabetes mellitus	0.000114	0.000508	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000114	0.000508	CbGpPWpGaD
Raltegravir—Asthenia—Ramipril—type 2 diabetes mellitus	0.000113	0.000225	CcSEcCtD
Raltegravir—Pruritus—Ramipril—type 2 diabetes mellitus	0.000112	0.000222	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	0.000111	0.000493	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CBS—type 2 diabetes mellitus	0.00011	0.000487	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ABCC8—type 2 diabetes mellitus	0.00011	0.000487	CbGpPWpGaD
Raltegravir—Nausea—Losartan—type 2 diabetes mellitus	0.000109	0.000217	CcSEcCtD
Raltegravir—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000108	0.000215	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	0.000106	0.00047	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NOS3—type 2 diabetes mellitus	0.000106	0.00047	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—COX2—type 2 diabetes mellitus	0.000106	0.000469	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000106	0.000469	CbGpPWpGaD
Raltegravir—Dizziness—Ramipril—type 2 diabetes mellitus	0.000104	0.000207	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—NCOA6—type 2 diabetes mellitus	0.000104	0.000461	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UCP2—type 2 diabetes mellitus	0.000102	0.000453	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—UCP3—type 2 diabetes mellitus	0.000102	0.000453	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000102	0.000453	CbGpPWpGaD
Raltegravir—Vomiting—Ramipril—type 2 diabetes mellitus	0.0001	0.000199	CcSEcCtD
Raltegravir—CCR1—Signaling Pathways—RELA—type 2 diabetes mellitus	9.97e-05	0.000443	CbGpPWpGaD
Raltegravir—Rash—Ramipril—type 2 diabetes mellitus	9.94e-05	0.000198	CcSEcCtD
Raltegravir—Dermatitis—Ramipril—type 2 diabetes mellitus	9.93e-05	0.000198	CcSEcCtD
Raltegravir—Headache—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000196	CcSEcCtD
Raltegravir—UGT1A1—Metabolism—PCK1—type 2 diabetes mellitus	9.59e-05	0.000426	CbGpPWpGaD
Raltegravir—Nausea—Ramipril—type 2 diabetes mellitus	9.36e-05	0.000186	CcSEcCtD
Raltegravir—CCR1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.07e-05	0.000403	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—CASP3—type 2 diabetes mellitus	8.99e-05	0.000399	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HK1—type 2 diabetes mellitus	8.98e-05	0.000399	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—IL6—type 2 diabetes mellitus	8.93e-05	0.000397	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCKR—type 2 diabetes mellitus	8.67e-05	0.000385	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPA—type 2 diabetes mellitus	8.67e-05	0.000385	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—KCNJ11—type 2 diabetes mellitus	8.67e-05	0.000385	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HSD3B2—type 2 diabetes mellitus	8.67e-05	0.000385	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.5e-05	0.000377	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.41e-05	0.000373	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALDOB—type 2 diabetes mellitus	8.31e-05	0.000369	CbGpPWpGaD
Raltegravir—CCR1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.24e-05	0.000366	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—SRC—type 2 diabetes mellitus	7.83e-05	0.000348	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GLP1R—type 2 diabetes mellitus	7.73e-05	0.000343	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	7.63e-05	0.000339	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC2A2—type 2 diabetes mellitus	7.22e-05	0.000321	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MTR—type 2 diabetes mellitus	7.07e-05	0.000314	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CPT1A—type 2 diabetes mellitus	7.07e-05	0.000314	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7e-05	0.000311	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NAMPT—type 2 diabetes mellitus	6.93e-05	0.000308	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HBA1—type 2 diabetes mellitus	6.89e-05	0.000306	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LIPC—type 2 diabetes mellitus	6.89e-05	0.000306	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCK—type 2 diabetes mellitus	6.89e-05	0.000306	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—EGFR—type 2 diabetes mellitus	6.87e-05	0.000305	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.85e-05	0.000304	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.72e-05	0.000299	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CETP—type 2 diabetes mellitus	6.65e-05	0.000295	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PSMD6—type 2 diabetes mellitus	6.18e-05	0.000275	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SREBF1—type 2 diabetes mellitus	6.18e-05	0.000275	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SNAP25—type 2 diabetes mellitus	6.18e-05	0.000275	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CTGF—type 2 diabetes mellitus	6.07e-05	0.000269	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMGCR—type 2 diabetes mellitus	6.01e-05	0.000267	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.88e-05	0.000261	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.65e-05	0.000251	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.59e-05	0.000248	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.59e-05	0.000248	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.45e-05	0.000242	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GCG—type 2 diabetes mellitus	5.36e-05	0.000238	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.36e-05	0.000238	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—IL6—type 2 diabetes mellitus	5.28e-05	0.000234	CbGpPWpGaD
Raltegravir—CCR1—Signaling Pathways—AKT1—type 2 diabetes mellitus	4.87e-05	0.000216	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GNB3—type 2 diabetes mellitus	4.62e-05	0.000205	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.62e-05	0.000205	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—HMOX1—type 2 diabetes mellitus	4.6e-05	0.000204	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CAT—type 2 diabetes mellitus	4.54e-05	0.000202	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOB—type 2 diabetes mellitus	4.4e-05	0.000196	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GSTM1—type 2 diabetes mellitus	4.28e-05	0.00019	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—LPL—type 2 diabetes mellitus	4.2e-05	0.000187	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ADCY5—type 2 diabetes mellitus	4.12e-05	0.000183	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—GPX1—type 2 diabetes mellitus	4.1e-05	0.000182	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CD36—type 2 diabetes mellitus	3.99e-05	0.000177	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.94e-05	0.000175	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—MTHFR—type 2 diabetes mellitus	3.79e-05	0.000168	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARA—type 2 diabetes mellitus	3.71e-05	0.000165	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AGT—type 2 diabetes mellitus	3.6e-05	0.00016	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—CALM1—type 2 diabetes mellitus	3.54e-05	0.000157	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOE—type 2 diabetes mellitus	3.52e-05	0.000157	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—APOA1—type 2 diabetes mellitus	3.48e-05	0.000155	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PPARG—type 2 diabetes mellitus	3.07e-05	0.000136	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—INS—type 2 diabetes mellitus	3.01e-05	0.000134	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—ALB—type 2 diabetes mellitus	2.76e-05	0.000123	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—NOS3—type 2 diabetes mellitus	2.64e-05	0.000117	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.64e-05	0.000117	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—PTGS2—type 2 diabetes mellitus	2.41e-05	0.000107	CbGpPWpGaD
Raltegravir—UGT1A1—Metabolism—AKT1—type 2 diabetes mellitus	1.21e-05	5.39e-05	CbGpPWpGaD
